Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Relief Therapeutics (OTCMKTS:RLFTF) Stock Gains After Results of Extraordinary General Meeting of Shareholders

Relief Therapeutics (OTCMKTS:RLFTF), a biopharmaceutical company, committedto delivering innovative treatment options for those suffering from rare diseases, on April 28, 2023, announced the results of an extraordinary general meeting held in Geneva. The company confirmed that all proposals were approved by a large majority of shareholders. Trading Data On Friday, RLFTF stock surged 5.88% to …

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Stock Continues To Move Up

Yesterday the biopharmaceutical company Relief Therapeutics Holding SA (OTCMKTS:RLFTF), which is involved in advancing treatments for benefitting the lives of patients suffering from rare conditions, made a key announcement. Trading Data On Monday, RLFTF stock increased 1.55% to $0.0230 with more than 528.32K shares, compared to its average volume of 944.75K shares. The stock moved …

5 Foreign OTC Stocks To Radar Now: SHNJF, NEXCF, RLFTF, FUNFF, ELNSF

Following were the most active stock buzzers on Monday. Keep an eye on these stocks this week. If you are interested in nanocap stocks here is one you should look into Rogue Baron plc (OTCMKTS:SHNJF) is a premium liquor brand developer that is angling to become the next multi-million dollar buyout success story.  Its award–winning …

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) : Subsidiary Gets Notice of Allowance of Key U.S. Patent Application Including PKU GOLIKE(R)

Biopharmaceutical company, Relief Therapeutics Holding SA (OTCMKTS:RLFTF) (striving to provide patients therapeutic relief from serious diseases with high unmet need), has made an announcement that its wholly owned subsidiary, APR Applied Pharma Research, has officially received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for Patent Application No. 15/303,121 entitled, “Modified …